Mangoceuticals, Historical Balance Sheet
| MGRX Stock | 2.38 0.09 3.64% |
Trend analysis of Mangoceuticals, Common Stock balance sheet accounts such as Total Stockholder Equity of 14.6 M provides information on Mangoceuticals, Common's total assets, liabilities, and equity, which is the actual value of Mangoceuticals, Common to its prevalent stockholders. By breaking down trends over time using Mangoceuticals, Common balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Mangoceuticals, Common latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Mangoceuticals, Common is a good buy for the upcoming year.
Mangoceuticals, |
About Mangoceuticals, Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Mangoceuticals, Common at a specified time, usually calculated after every quarter, six months, or one year. Mangoceuticals, Common Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Mangoceuticals, Common and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Mangoceuticals, currently owns. An asset can also be divided into two categories, current and non-current.
Mangoceuticals, Common Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Mangoceuticals, Common assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Mangoceuticals, Common books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Mangoceuticals, Common balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Mangoceuticals, Common Stock are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Cash And Short Term Investments
Short Term Investments is an account in the current assets section of Mangoceuticals, Common balance sheet. This account contains Mangoceuticals, Common investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Mangoceuticals, Common Stock fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.Most accounts from Mangoceuticals, Common's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Mangoceuticals, Common current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mangoceuticals, Common Stock. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. At this time, Mangoceuticals, Common's Total Assets are fairly stable compared to the past year. Total Current Liabilities is likely to rise to about 1.5 M in 2025, whereas Short and Long Term Debt Total is likely to drop slightly above 202.3 K in 2025.
| 2022 | 2023 | 2024 | 2025 (projected) | Short and Long Term Debt Total | 352.9K | 128.7K | 215.0K | 202.3K | Total Assets | 1.0M | 1.1M | 15.4M | 16.1M |
Mangoceuticals, Common balance sheet Correlations
Click cells to compare fundamentals
Mangoceuticals, Common Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Tools for Mangoceuticals, Stock Analysis
When running Mangoceuticals, Common's price analysis, check to measure Mangoceuticals, Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mangoceuticals, Common is operating at the current time. Most of Mangoceuticals, Common's value examination focuses on studying past and present price action to predict the probability of Mangoceuticals, Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mangoceuticals, Common's price. Additionally, you may evaluate how the addition of Mangoceuticals, Common to your portfolios can decrease your overall portfolio volatility.